BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1372 related articles for article (PubMed ID: 23644491)

  • 21. Epigenetic regulation by BAF (mSWI/SNF) chromatin remodeling complexes is indispensable for embryonic development.
    Nguyen H; Sokpor G; Pham L; Rosenbusch J; Stoykova A; Staiger JF; Tuoc T
    Cell Cycle; 2016 May; 15(10):1317-24. PubMed ID: 26986003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biallelic germline and somatic mutations in malignant mesothelioma: multiple mutations in transcription regulators including mSWI/SNF genes.
    Yoshikawa Y; Sato A; Tsujimura T; Otsuki T; Fukuoka K; Hasegawa S; Nakano T; Hashimoto-Tamaoki T
    Int J Cancer; 2015 Feb; 136(3):560-71. PubMed ID: 24916674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer.
    Hodges C; Kirkland JG; Crabtree GR
    Cold Spring Harb Perspect Med; 2016 Aug; 6(8):. PubMed ID: 27413115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential Contributions of mSWI/SNF Chromatin Remodeler Sub-Families to Myoblast Differentiation.
    Padilla-Benavides T; Olea-Flores M; Sharma T; Syed SA; Witwicka H; Zuñiga-Eulogio MD; Zhang K; Navarro-Tito N; Imbalzano AN
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers.
    Alver BH; Kim KH; Lu P; Wang X; Manchester HE; Wang W; Haswell JR; Park PJ; Roberts CW
    Nat Commun; 2017 Mar; 8():14648. PubMed ID: 28262751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities.
    Orlando KA; Nguyen V; Raab JR; Walhart T; Weissman BE
    Expert Rev Anticancer Ther; 2019 May; 19(5):375-391. PubMed ID: 30986130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations in the composition of mammalian SWI/SNF chromatin remodelling complexes.
    Ryme J; Asp P; Böhm S; Cavellán E; Farrants AK
    J Cell Biochem; 2009 Oct; 108(3):565-76. PubMed ID: 19650111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vulnerabilities of mutant SWI/SNF complexes in cancer.
    Helming KC; Wang X; Roberts CWM
    Cancer Cell; 2014 Sep; 26(3):309-317. PubMed ID: 25203320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL.
    Baliñas-Gavira C; Rodríguez MI; Andrades A; Cuadros M; Álvarez-Pérez JC; Álvarez-Prado ÁF; de Yébenes VG; Sánchez-Hernández S; Fernández-Vigo E; Muñoz J; Martín F; Ramiro AR; Martínez-Climent JA; Medina PP
    Leukemia; 2020 Oct; 34(10):2722-2735. PubMed ID: 32576963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities.
    Andrades A; Peinado P; Alvarez-Perez JC; Sanjuan-Hidalgo J; García DJ; Arenas AM; Matia-González AM; Medina PP
    Mol Cancer; 2023 Feb; 22(1):39. PubMed ID: 36810086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.
    Wang X; Sansam CG; Thom CS; Metzger D; Evans JA; Nguyen PT; Roberts CW
    Cancer Res; 2009 Oct; 69(20):8094-101. PubMed ID: 19789351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rationale to target the SWI/SNF complex for cancer therapy.
    Hohmann AF; Vakoc CR
    Trends Genet; 2014 Aug; 30(8):356-63. PubMed ID: 24932742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BCL7A and BCL7B potentiate SWI/SNF-complex-mediated chromatin accessibility to regulate gene expression and vegetative phase transition in plants.
    Lei Y; Yu Y; Fu W; Zhu T; Wu C; Zhang Z; Yu Z; Song X; Xu J; Liang Z; Lü P; Li C
    Nat Commun; 2024 Jan; 15(1):935. PubMed ID: 38296999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional selectivity of recombinant mammalian SWI/SNF subunits.
    Kadam S; McAlpine GS; Phelan ML; Kingston RE; Jones KA; Emerson BM
    Genes Dev; 2000 Oct; 14(19):2441-51. PubMed ID: 11018012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential requirements for different subfamilies of the mammalian SWI/SNF chromatin remodeling enzymes in myoblast cell cycle progression and expression of the Pax7 regulator.
    Padilla-Benavides T; Olea-Flores M; Nshanji Y; Maung MT; Syed SA; Imbalzano AN
    Biochim Biophys Acta Gene Regul Mech; 2022 Feb; 1865(2):194801. PubMed ID: 35217218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico screening of cancer-associated mutations in the HSA domain of BRG1 and its role in affecting the Arp-HSA sub-complex of SWI/SNF.
    S AS; Goutham R N A; Mohan S S
    Comput Biol Chem; 2018 Dec; 77():109-115. PubMed ID: 30286321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced SMARCD1, a subunit of the SWI/SNF complex, promotes liver cancer growth through the mTOR pathway.
    Zhou Y; Xu Q; Tao L; Chen Y; Shu Y; Wu Z; Lu C; Shi Y; Bu H
    Clin Sci (Lond); 2020 Jun; 134(12):1457-1472. PubMed ID: 32514535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A SMARCD2-containing mSWI/SNF complex is required for granulopoiesis.
    Michel BC; Kadoch C
    Nat Genet; 2017 Apr; 49(5):655-657. PubMed ID: 28442792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity.
    Cyrta J; Augspach A; De Filippo MR; Prandi D; Thienger P; Benelli M; Cooley V; Bareja R; Wilkes D; Chae SS; Cavaliere P; Dephoure N; Uldry AC; Lagache SB; Roma L; Cohen S; Jaquet M; Brandt LP; Alshalalfa M; Puca L; Sboner A; Feng F; Wang S; Beltran H; Lotan T; Spahn M; Kruithof-de Julio M; Chen Y; Ballman KV; Demichelis F; Piscuoglio S; Rubin MA
    Nat Commun; 2020 Nov; 11(1):5549. PubMed ID: 33144576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.
    Tsuda M; Fukuda A; Kawai M; Araki O; Seno H
    Cancer Sci; 2021 Feb; 112(2):490-497. PubMed ID: 33301642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.